Zecotek Photonics (Zecotek Photonics) ROCE % : 0.00% (As of Apr. 2020)

View and export this data going back to 2003. Start your Free Trial

What is Zecotek Photonics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zecotek Photonics's annualized ROCE % for the quarter that ended in Apr. 2020 was 0.00%.

Zecotek Photonics ROCE % Historical Data

The historical data trend for Zecotek Photonics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zecotek Photonics ROCE % Chart

Zecotek Photonics Annual Data

Trend

Jul10

Jul11

Jul12

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

ROCE %

Get a 7-Day Free Trial

Zecotek Photonics Quarterly Data
	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Zecotek Photonics ROCE % Calculation

Zecotek Photonics's annualized ROCE % for the fiscal year that ended in Jul. 2019 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jul. 2019 )		(A: Jul. 2018 )		(A: Jul. 2019 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jul. 2019 )		(A: Jul. 2018 )		(A: Jul. 2019 )
	=	-3.664	/	( ( (3.239 - 2.88)	+	(2.578 - 5.88) )	/ 2 )
	=	-3.664	/	( (0.359	+	-3.302)	/ 2 )
	=	-3.664	/	-1.4715
	=	249.00 %

Zecotek Photonics's ROCE % of for the quarter that ended in Apr. 2020 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Apr. 2020 )		(Q: Jan. 2020 )		(Q: Apr. 2020 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Apr. 2020 )		(Q: Jan. 2020 )		(Q: Apr. 2020 )
	=	-0.996	/	( ( (9.299 - 13.872)	+	(2.042 - 5.671) )	/ 2 )
	=	-0.996	/	( ( -4.573	+	-3.629 )	/ 2 )
	=	-0.996	/	-4.101
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2020) EBIT data.

Zecotek Photonics (OTCPK:ZMSPF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zecotek Photonics ROCE % Related Terms

Thank you for viewing the detailed overview of Zecotek Photonics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zecotek Photonics (Zecotek Photonics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zecotek Photonics Inc (OTCPK:ZMSPF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6900 Graybar Road, Unit 2325, Richmond, BC, CAN, V6W 0A5

Website

http://www.zecotek.com

Zecotek Photonics Inc is in the business of research and development of photonics technologies. The company is focused on creating advanced materials and integrated optoelectronic devices for high-resolution medical imaging, optical precision surgery, and biopharmaceutical research. It operates in three divisions which include Imaging systems, Optronics systems, and 3D display systems with labs located in Canada, Korea, Russia, Singapore, and the U.S.A. The company develops products such as scintillation crystals, solid-state, photodetectors, positron emission tomography scanning components, lasers, and 3D display and 3D printing technologies. These products are used in sectors such as healthcare, scientific and industrial.